BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.
Investors
All regulatory information and reports.
Clinical studies
Discover all the details of our clinical studies.
Véronique Pomi-Schneiter stands down as BioSenic's Deputy CEO
Arsenic Trioxide
An innovative drug to treat autoimmune diseases at the source of the immune cascade.
Our technology
BioSenic offers a unique treatment value by developing two innovative product lines: an arsenic trioxide-based treatment for autoimmune diseases and cell therapy products.